Data updated: Mar 10, 2026
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
FEXOFENADINE HYDROCHLORIDE
Approved 2005-04-14
9
Indications
--
Phase 3 Trials
20
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2005-04-14
- Routes
- ORAL
- Dosage Forms
- TABLET, EXTENDED RELEASE
Companies
Website: ↗
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE Approval History
Loading approval history...
What FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE Treats
9 FDA approvalsOriginally approved for its first indication in 2005 . Covers 9 distinct patient populations.
- Other (9)
Other
(9 approvals)- • Approved indication (Apr 2005)Letter
- • Approved indication (Mar 2010)
- • Approved indication (Nov 2010)
- • Approved indication (Nov 2014)
- • Approved indication (Jan 2015)
- • Approved indication (Oct 2017)
- • Approved indication (May 2022)
- • Approved indication (Apr 2025) New
- • Approved indication (Oct 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.